These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 20404121)
1. In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center. Zapor MJ; Barber M; Summers A; Miller GH; Feeney LA; Eberly LE; Wortmann G Antimicrob Agents Chemother; 2010 Jul; 54(7):3015-7. PubMed ID: 20404121 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii. Juhas M; Widlake E; Teo J; Huseby DL; Tyrrell JM; Polikanov YS; Ercan O; Petersson A; Cao S; Aboklaish AF; Rominski A; Crich D; Böttger EC; Walsh TR; Hughes D; Hobbie SN J Antimicrob Chemother; 2019 Apr; 74(4):944-952. PubMed ID: 30629184 [TBL] [Abstract][Full Text] [Related]
4. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates]. Turk Dagi H; Kus H; Arslan U; Tuncer I Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268 [TBL] [Abstract][Full Text] [Related]
5. In vitro antimicrobial activity of the aminoglycoside arbekacin tested against oxacillin-resistant Staphylococcus aureus isolated in Brazilian hospitals. Cordeiro JC; Reis AO; Miranda EA; Sader HS; Braz J Infect Dis; 2001 Jun; 5(3):130-5. PubMed ID: 11506776 [TBL] [Abstract][Full Text] [Related]
6. Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumonia. Sader HS; Rhomberg PR; Farrell DJ; Jones RN Antimicrob Agents Chemother; 2015; 59(6):3263-70. PubMed ID: 25801559 [TBL] [Abstract][Full Text] [Related]
7. Emergence of Aminoglycoside Resistance Due to armA methylase in Multi-drug Resistant Acinetobacter Baumannii Isolates in a University Hospital in Nepal. Shrestha S; Tada T; Shrestha B; Kirikae T; Ohara H; Rijal BP; Pokhrel BM; Sherchand JB J Nepal Health Res Counc; 2016 May; 14(33):72-76. PubMed ID: 27885285 [TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan. Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan. Liu JY; Wang FD; Ho MW; Lee CH; Liu JW; Wang JT; Sheng WH; Hseuh PR; Chang SC J Microbiol Immunol Infect; 2016 Dec; 49(6):918-923. PubMed ID: 26364729 [TBL] [Abstract][Full Text] [Related]
10. In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates. Hong DJ; Kim JO; Lee H; Yoon EJ; Jeong SH; Yong D; Lee K Diagn Microbiol Infect Dis; 2016 Oct; 86(2):184-9. PubMed ID: 27475960 [TBL] [Abstract][Full Text] [Related]
11. In Vitro Efficacy of Doripenem against Pseudomonas aeruginosa and Acinetobacter baumannii by E-Test. Gilani M; Munir T; Latif M; Rehman S; Ansari M; Hafeez A; Najeeb S; Saad N; Gilani M J Coll Physicians Surg Pak; 2015 Oct; 25(10):726-9. PubMed ID: 26454387 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City. Landman D; Kelly P; Bäcker M; Babu E; Shah N; Bratu S; Quale J J Antimicrob Chemother; 2011 Feb; 66(2):332-4. PubMed ID: 21131322 [TBL] [Abstract][Full Text] [Related]
13. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708 [TBL] [Abstract][Full Text] [Related]
14. Phenotypic and WGS-derived antimicrobial resistance profiles of clinical and non-clinical Acinetobacter baumannii isolates from Germany and Vietnam. Wareth G; Linde J; Hammer P; Nguyen NH; Nguyen TNM; Splettstoesser WD; Makarewicz O; Neubauer H; Sprague LD; Pletz MW Int J Antimicrob Agents; 2020 Oct; 56(4):106127. PubMed ID: 32750418 [TBL] [Abstract][Full Text] [Related]
15. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro]. Zhao C; Xie W; Zhang W; Ye Z; Wu H Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663 [TBL] [Abstract][Full Text] [Related]